LEADER 01216nam2-2200397---450-
001 990005796670203316
005 20150123123939.0
010   $a978-3-642-25760-5
035   $a000579667
035   $aUSA01000579667
035   $a(ALEPH)000579667USA01
035   $a000579667
100   $a20130116d2012----km-y0itay50------ba
101 0 $aeng
102   $aDE
105   $aa---||||001yy
200 1 $aCurrent Antipsychotics$fMark A. Geyer, Gerhard Gross
210   $aNew York$cSpringer$d2012
215   $aVII, 416 p.$d24 cm
225 2 $aHandbook of experimental pharmacology$v212
410  0$1001000320432$aHandbook of experimental pharmacology$v, 212
606 0 $aPsicopatologia$2BNCF
676   $a616.079
700  1$aGEYER,$bMark A.$0616245
701  1$aGROSS,$bGerhard$0616246
801  0$aIT$bsalbc$gISBD
912   $a990005796670203316
951   $a616.079 GEY 1$b5668 Farm.$c616$d00313122
959   $aBK
969   $aFAR
979   $aPASSARO$b90$c20130116$lUSA01$h1427
979   $aPASSARO$b90$c20130116$lUSA01$h1429
979   $aPATRY$b90$c20150123$lUSA01$h1237
979   $aPATRY$b90$c20150123$lUSA01$h1239
996   $aCurrent Antipsychotics$91080885
997   $aUNISA